Back to Journals » Neuropsychiatric Disease and Treatment » Volume 14

Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials

Total article views   Abstract views HTML views PDF downloads Totals
5,907 Dovepress* 4,817 688+ 820 5,505
PubMed Central* 0 402 221 402
Totals 4,817 1,090 1,041 5,907
*Since 1 October 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
15 1 0 0 6 8

View citations on PubMed Central and Google Scholar